BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1997164)

  • 1. Survival and causes of death in thyroid cancer: a population-based study of 2479 cases from Norway.
    Akslen LA; Haldorsen T; Thoresen SO; Glattre E
    Cancer Res; 1991 Feb; 51(4):1234-41. PubMed ID: 1997164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of thyroid cancer in Norway 1970-1985. Population review on time trend, sex, age, histological type and tumour stage in 2625 cases.
    Akslen LA; Haldorsen T; Thoresen SO; Glattre E
    APMIS; 1990 Jun; 98(6):549-58. PubMed ID: 2383397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical treatment of papillary and follicular thyroid carcinoma.
    Lin JD; Jeng LB; Chao TC; Weng HF; Huang HS
    Int Surg; 1996; 81(1):61-6. PubMed ID: 8803709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric cancer: correlation between clinicopathological factors and survival of patients (III).
    Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
    Rom J Morphol Embryol; 2009; 50(3):369-79. PubMed ID: 19690762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based outcomes for pediatric thyroid carcinoma.
    Shapiro NL; Bhattacharyya N
    Laryngoscope; 2005 Feb; 115(2):337-40. PubMed ID: 15689762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic factors influencing survival after surgical treatment of well differentiated thyroid cancer].
    Nowak W; Szybiński P; Nowak K; Stachura J; Popiela T
    Wiad Lek; 2004; 57(9-10):431-7. PubMed ID: 15765757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
    Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
    Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mortality of patients with differentiated thyroid carcinoma in Norway. The influence of sex, age, tumor stage, histologic type and residence at the time of diagnosis].
    Akslen LA; Thoresen SO; Glattre E; Haldorsen T; Schoultz M
    Tidsskr Nor Laegeforen; 1989 Jun; 109(16):1765-9. PubMed ID: 2749651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial occurrence of nonmedullary thyroid cancer: a population-based study of 5673 first-degree relatives of thyroid cancer patients from Norway.
    Frich L; Glattre E; Akslen LA
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):113-7. PubMed ID: 11219767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidity in newly diagnosed thyroid cancer patients: a population-based study on prevalence and the impact on treatment and survival.
    Kuijpens JL; Janssen-Heijnen ML; Lemmens VE; Haak HR; Heijckmann AC; Coebergh JW
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):450-5. PubMed ID: 16584519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
    Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
    J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors of insular versus papillary/follicular thyroid carcinoma.
    Falvo L; Catania A; D'Andrea V; Grilli P; D'Ercole C; De Antoni E
    Am Surg; 2004 May; 70(5):461-6. PubMed ID: 15156957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular thyroid carcinoma: histology and prognosis.
    D'Avanzo A; Treseler P; Ituarte PH; Wong M; Streja L; Greenspan FS; Siperstein AE; Duh QY; Clark OH
    Cancer; 2004 Mar; 100(6):1123-9. PubMed ID: 15022277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
    Gemsenjäger E; Heitz PU; Martina B; Schweizer I
    Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causes of late deaths after pediatric cardiac surgery: a population-based study.
    Nieminen HP; Jokinen EV; Sairanen HI
    J Am Coll Cardiol; 2007 Sep; 50(13):1263-71. PubMed ID: 17888844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid cancer incidence and survival among European children and adolescents (1978-1997): report from the Automated Childhood Cancer Information System project.
    Steliarova-Foucher E; Stiller CA; Pukkala E; Lacour B; Plesko I; Parkin DM
    Eur J Cancer; 2006 Sep; 42(13):2150-69. PubMed ID: 16919778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.